BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2897175)

  • 1. Intrathecal somatostatin in rats: antinociception only in the presence of toxic effects.
    Gaumann DM; Yaksh TL
    Anesthesiology; 1988 May; 68(5):733-42. PubMed ID: 2897175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal somatostatin in cat and mouse studies on pain, motor behavior, and histopathology.
    Gaumann DM; Yaksh TL; Post C; Wilcox GL; Rodriguez M
    Anesth Analg; 1989 May; 68(5):623-32. PubMed ID: 2566288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. I. Injection procedures modify pharmacological responses.
    Long JB; Mobley WC; Holaday JW
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1158-66. PubMed ID: 2901486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal and epidural somatostatin in rats: can antinociception, motor effects and neurotoxicity be separated?
    Mollenholt P; Post C; Paulsson I; Rawal N
    Pain; 1990 Dec; 43(3):363-370. PubMed ID: 1981389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal morphine and clonidine: antinociceptive tolerance and cross-tolerance and effects on blood pressure.
    Solomon RE; Gebhart GF
    J Pharmacol Exp Ther; 1988 May; 245(2):444-54. PubMed ID: 3367301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat.
    Björkman R
    Acta Anaesthesiol Scand Suppl; 1995; 103():1-44. PubMed ID: 7725891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a central long-lasting antinociceptive effect of vapreotide, an analog of somatostatin, involving an opioidergic mechanism.
    Betoin F; Ardid D; Herbet A; Aumaitre O; Kemeny JL; Duchene-Marullaz P; Lavarenne J; Eschalier A
    J Pharmacol Exp Ther; 1994 Apr; 269(1):7-14. PubMed ID: 7909563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive and 'neurotoxic' actions of somatostatin in rat spinal cord after intrathecal administration.
    Mollenholt P; Post C; Rawal N; Freedman J; Hökfelt T; Paulsson I
    Pain; 1988 Jan; 32(1):95-105. PubMed ID: 2893326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the role of A1/A2 adenosine receptors mediating the purine antinociception, motor and autonomic function in the rat spinal cord.
    Sosnowski M; Stevens CW; Yaksh TL
    J Pharmacol Exp Ther; 1989 Sep; 250(3):915-22. PubMed ID: 2778719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal somatostatin, somatostatin analogs, substance P analog and dynorphin A cause comparable neurotoxicity in rats.
    Gaumann DM; Grabow TS; Yaksh TL; Casey SJ; Rodriguez M
    Neuroscience; 1990; 39(3):761-74. PubMed ID: 1711172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ciprofloxacin and gentamicin on spinal morphine-induced antinociception in rats.
    Luger TJ; Farkas W; Geisler H; Lorenz IH
    Basic Clin Pharmacol Toxicol; 2005 May; 96(5):366-74. PubMed ID: 15853929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal ketorolac in dogs and rats.
    Yaksh TL; Horais KA; Tozier N; Rathbun M; Richter P; Rossi S; Grafe M; Tong C; Meschter C; Cline JM; Eisenach J
    Toxicol Sci; 2004 Aug; 80(2):322-34. PubMed ID: 15141096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. II. Nonopioid mechanisms mediate loss of motor, sensory and autonomic function.
    Long JB; Petras JM; Mobley WC; Holaday JW
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1167-74. PubMed ID: 2901487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociception and delta-1 opioid receptors in the rat spinal cord: studies with intrathecal 7-benzylidenenaltrexone.
    Hammond DL; Stewart PE; Littell L
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1317-24. PubMed ID: 7562504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenergic, serotonergic and cholinergic components of nicotinic antinociception in rats.
    Iwamoto ET; Marion L
    J Pharmacol Exp Ther; 1993 May; 265(2):777-89. PubMed ID: 8388459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between motor paralysis and neurotoxicity induced by intrathecal dynorphin A (1-17) in rats].
    Cui CL; Wu LZ; Han JS
    Yao Xue Xue Bao; 1997; 32(2):85-9. PubMed ID: 11243205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression of nociceptive sensory activity in the rat spinal cord due to the intrathecal administration of drugs: effect of diazepam.
    Jurna I
    Neurosurgery; 1984 Dec; 15(6):917-20. PubMed ID: 6096760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplicative interaction between narcotic agonisms expressed at spinal and supraspinal sites of antinociceptive action as revealed by concurrent intrathecal and intracerebroventricular injections of morphine.
    Yeung JC; Rudy TA
    J Pharmacol Exp Ther; 1980 Dec; 215(3):633-42. PubMed ID: 6893721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple spinal mediators in parenteral nicotine-induced antinociception.
    Rogers DT; Iwamoto ET
    J Pharmacol Exp Ther; 1993 Oct; 267(1):341-9. PubMed ID: 7901397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.
    Schmauss C; Yaksh TL
    J Pharmacol Exp Ther; 1984 Jan; 228(1):1-12. PubMed ID: 6319664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.